Helius Medical Technologies, Inc.HSDT
NASDAQ > Medical - Devices
DCF:$1.04 | P/E: -
$0.13(-14.41%)
Change Rating:
Price: $0.91 USD
Market Cap: $2.90M
...Loading HSDT Peers...
Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma. Its product, Portable Neuromodulation Stimulator (PoNS), is a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. The company is headquartered in Newtown, Pennsylvania.
22 Employees
CEO : Mr. Dane Carl Andreeff
Address : 642 Newtown Yardley Road, Newtown,PA, US, - 18940,
| Key Excutives | Designation |
|---|---|
| Dr. Antonella Favit-Van Pelt M.D., Ph.D. | Chief Medical Officer |
| Mr. Jeffrey S. Mathiesen CPA | Chief Financial Officer, Treasurer, Secretary & Director |
| Mr. Dane Carl Andreeff | President, Chief Executive Officer & Director |
| Mr. Lawrence Picciano | Senior Vice President of Engineering, Quality & Regulatory Affairs |